This gradual glucose release, in turn, leads to increased GLP-1 secretion
GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) are subcutaneous injections for type 2 diabetes and weight management
A systematic approach to standardizing drinking outcomes from timeline followback data
Impact of seasons and festivals on the onset of acute pancreatitis in Shanghai, China
The development of GLP-1 medications has provided a medical intervention that addresses the complex biological factors contributing to obesity
The Wegovy label now includes single-dose pens across the strength range plus a Wegovy HD 7.2 mg presentation, single-dose syringes, and a single-patient-use Wegovy FlexTouch pen at 9.6 mg/3 mL delivering four 2.4 mg doses